1. World Health Organization. Development of Paediatric Medicines: Points to Consider in Pharmaceutical Development. Working Document QAS/08.257/Rev.3 http://www.who.int/medicines/areas/quality_safety/quality_assurance/Rev3-PaediatricMedicinesDevelopment_QAS08-257Rev3_17082011.pdf (last accessed 01.03.12).
2. World Health Organization, 2010. Model formulary for children. http://www.who.int/selection_medicines/list/WMFc_2010.pdf (last accessed 01.03.12).
3. World Health Organization, 2012b. Pharmaceutical Development for Multisource (Generic) Pharmaceutical Products. Working Document QAS/08.251/Rev.3 http://www.who.int/medicines/services/expertcommittees/pharmprep/150510-PharmDevelGener_QAS08_251Rev1.pdf (last accessed 01.03.12).
4. World Health Organization, 2008. Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children. December 2008 http://www.who.int/selection_medicines/committees/expert/17/application/paediatric/Dosage_form_reportDEC2008.pdf (last accessed 01.03.12).